Learning Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Keyword
Search by Category
Search in Packages
Search by Format
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Contains 19 Product(s)

    INS 2024 Virtual Conference will provide a great alternative for those who are not able to attend the in-person event. Participants will have the ability to attend 18 select sessions virtually and on-demand. This option also enables CRNI®s to earn up to 36 recertification units (RUs). The virtual conference will include some of the sessions in the Vascular Access Device (VAD) Track devoted to an important aspect of infusion therapy, vascular access devices as well as sessions included in the Alternative Care Setting Track dedicated to the care of patients outside of acute care settings.

    INS 2024 Virtual Conference will provide a great alternative for those who are not able to attend the in-person event. Participants will have the ability to attend 18 select sessions virtually and on-demand. This option also enables CRNI®s to earn up to 36 recertification units (RUs). The virtual conference will include some of the sessions in the Vascular Access Device (VAD) Track devoted to an important aspect of infusion therapy, vascular access devices as well as sessions included in the Alternative Care Setting Track dedicated to the care of patients outside of acute care settings.

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 03/06/2024 at 1:00 PM (EST)

    Did you know that the properties of Infusion therapy play a crucial role in determining the most appropriate vascular access device for patients? They are critical factors to consider and can have a significant impact on patient care and outcomes. By understanding the importance of these properties, we can ensure that our patients receive the best possible treatment. During this session, we will explore this topic further to ensure we provide the best care for our patients.

    image

    Did you know that the properties of Infusion therapy play a crucial role in determining the most appropriate vascular access device for patients? They are critical factors to consider and can have a significant impact on patient care and outcomes. By understanding the importance of these properties, we can ensure that our patients receive the best possible treatment. During this session, we will explore this topic further to ensure we provide the best care for our patients.

    Learning Objectives: At the conclusion of this session, learners will be able to:

    • Define up-to-date clinical standards of pharmacokinetics of vascular infusions, medications, and treatment as relates to patient safety and vessel preservation.
    • Identify evidence-based practices for potential complications of peripheral and central vascular access devices.
    • Discuss clinical indications, evaluations, and rationales for evidence-based practice regarding vessel preservation complexities.
    • Discuss clinical indicators related to evidence-based practice for vascular access devices and their complications in various patient populations.

    Carla Dillard, MSN, RN, VA-BC

    Carla is the current chief nursing officer for Dynamic Access. She is responsible for overseeing the clinical and regulatory compliance of the organization. Carla has been with Dynamic since 2005 and has held various leadership roles in the development of clinical, operational, and educational components of the organization. Before joining Dynamic, Carla worked as a registered nurse in acute care emergency and intensive care units. She established an educational company in 2013 to address deficiencies in clinical bedside care. Motivated by her passion for education, Carla remains dedicated to bridging these gaps.

    Katie Nesbitt, PharmD, BCPS

    Katie Nesbitt, PharmD, BCPS, received her Doctorate in Pharmacy from Philadelphia College of Pharmacy and completed a PGY1 general pharmacy residency at Tower Health Network in Reading, Pennsylvania.  After working at Tower Health Network for 5 years, she transitioned into a clinical pharmacy specialist role focused in cardiology and anticoagulation at Lehigh Valley Health Network. She currently serves as a clinical pharmacy consultant for RxToolKit.  Dr. Nesbitt is a board-certified pharmacotherapy specialist. Utilizing her current roles and experiences, she is able to pursue her passion for educating in areas including critical care pharmacotherapy and cardiology-related medication topics.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: March 6, 2027

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 6 Product(s)

    Join us for a deep dive into the all-new 2024 INS Standards of Practice. This 2-day symposium will provide a comprehensive overview of the revisions introduced in the 9th edition. At the conclusion of the meeting, you will be able to claim 5 contact hours and 10 CRNI® recertification units.

    Join us for a deep dive into the all-new 2024 INS Standards of Practice. This 2-day symposium will provide a comprehensive overview of the revisions introduced in the 9th edition. At the conclusion of the meeting, you will be able to claim 5 contact hours and 10 CRNI® recertification units.

  • Contains 3 Component(s), Includes Credits Recorded On: 01/17/2024

    Smart infusion pumps have been around for over 20 years and represent one of the most valuable pieces of health care technology in place to promote patient safety. By allowing significant control over how intravenous medications are administered, errors can be prevented prior to them reaching the patient. A good catch is when smart infusion pump programming triggers an alert for a value that is considered unsafe and temporarily stops additional forward programming of the smart infusion pump. In this session, we will review examples of good catches, discuss how health care systems can quantify cost savings from severe harms averted, and explain how to champion smart pumps as a key tool to safely administer intravenous medications.

    Smart infusion pumps have been around for over 20 years and represent one of the most valuable pieces of health care technology in place to promote patient safety.  By allowing significant control over how intravenous medications are administered, errors can be prevented prior to them reaching the patient. A good catch is when smart infusion pump programming triggers an alert for a value that is considered unsafe and temporarily stops additional forward programming of the smart infusion pump. In this session, we will review examples of good catches, discuss how health care systems can quantify cost savings from severe harms averted, and explain how to champion smart pumps as a key tool to safely administer intravenous medications.

    Learning Objectives: At the conclusion of this session, learners will be able to: 

    1.     Discuss literature on the use of smart infusion pumps and Dose Error Reduction Software (DERS).

    2.     Define a good catch.

    3.     Describe how good catch data can be used to promote the use of smart infusion pumps to improve patient safety.

    Joanne Hatfield, PharmD, BCPS

    Joanne Hatfield, PharmD, BCPS, is the director of clinical solutions at Bainbridge Health, where she leads the analysis and interpretation of network data in order to provide actionable insights to improve medication safety. Dr. Hatfield also coordinates and provides educational activities for the National Infusion Collaborative, the largest collective of infusion practitioners across the United States. She previously served as clinical manager and cochair of the Pharmacy and Therapeutics Committee at University Health-Truman Medical Centers, where she was responsible for complete formulary oversight and clinical operations. Dr. Hatfield is board certified in pharmacotherapy and completed the ASHP Foundation Traineeship in Pain and Palliative Care.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: January 17, 2027

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits Recorded On: 11/15/2023

    Come learn how to handle the pitfalls in infusion nursing delivery. In this session, we will review the legal challenges with infusion nursing liability and offer reduction strategies. You will gain the tools you need in today’s lawsuit-prone health care system so you can protect one of your greatest assets—your nursing license. This is vital information for every infusion nurse.

    Come learn how to handle the pitfalls in infusion nursing delivery. In this session, we will review the legal challenges with infusion nursing liability and offer reduction strategies. You will gain the tools you need in today’s lawsuit-prone health care system so you can protect one of your greatest assets—your nursing license. This is vital information for every infusion nurse.

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    • Describe nursing negligence and malpractice and how it affects your everyday nursing practice.
    • Discuss two strategies to reduce your liability exposure.
    • Explain the four elements of nursing malpractice lawsuits that must be proven at trial.

    Elizabeth Rudolph, JD, MSN, RN, PLNC

    Elizabeth Rudolph, JD, MSN, RN, PLNC, is an attorney and nurse with many years of experience practicing health care law in Memphis, Tennessee. She obtained her Bachelor’s in Nursing, Master’s in Nursing, and law degree from Vanderbilt University in Nashville, Tennessee.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: November 15, 2026

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 7 Product(s)

    An INS task force was formed to review and update the 2017 vesicant list, identify current issues and risks relative to vesicant administration, and revise the extravasation prevention checklist. Presented by members of the task force, this INS virtual symposium addresses 5 challenging aspects of mitigating the risk of extravasations: identifying vesicants, optimal vascular access device and site choice, clinical practices to avoid extravasation, prevention of legalities with case study examples, and implementation of organizational policies and procedures. Extravasation may result in severe patient injuries including scarring, permanent functional impairment, and even loss of a limb. Such injuries are preventable when clinicians identify which medications and solutions are vesicants, understand infusion-related risks, and implement preventative interventions. At the conclusion of the meeting, you will be able to claim 5 contact hours and 10 CRNI® recertification units.

    An INS task force was formed to review and update the 2017 vesicant list, identify current issues and risks relative to vesicant administration, and revise the extravasation prevention checklist. Presented by members of the task force, this INS virtual symposium addresses 5 challenging aspects of mitigating the risk of extravasations: identifying vesicants, optimal vascular access device and site choice, clinical practices to avoid extravasation, prevention of legalities with case study examples, and implementation of organizational policies and procedures. Extravasation may result in severe patient injuries including scarring, permanent functional impairment, and even loss of a limb. Such injuries are preventable when clinicians identify which medications and solutions are vesicants, understand infusion-related risks, and implement preventative interventions. At the conclusion of the meeting, you will be able to claim 5 contact hours and 10 CRNI® recertification units.

  • Contains 1 Component(s) Recorded On: 01/07/2022

    There is a lack of standardized IV push medication preparation and administration teaching strategies used in nursing programs throughout the US. This lack of standardization creates an alarming variation in clinical practice that places patients at a higher risk of harm. A new Evidence-Based Practice guide and checklist of best practice standards Based on INS’s Infusion Therapy Standards of Practice and ISMP’s Safe Practice Guidelines for Adult IV Push Medications has been published to educate student nurses, novice nurses, and experienced nurses, to assess competency in skill acquisition related to IV push medication administration.

    There is a lack of standardized IV push medication preparation and administration teaching strategies used in nursing programs throughout the US. This lack of standardization creates an alarming variation in clinical practice that places patients at a higher risk of harm. A new Evidence-Based Practice guide and checklist of best practice standards Based on INS’s Infusion Therapy Standards of Practice and ISMP’s Safe Practice Guidelines for Adult IV Push Medications has been published to educate student nurses, novice nurses, and experienced nurses, to assess competency in skill acquisition related to IV push medication administration.

  • Contains 3 Component(s), Includes Credits Recorded On: 10/02/2023

    Thyroid eye disease (TED) is a serious, progressive autoimmune disease with a limited window for pharmacologic treatment during the active disease. During this window, the disease may respond to pharmacologic intervention. During this webinar, we will discuss the progression of thyroid eye disease, as well as the symptoms, causes, management, and treatment modalities.

    image

    Thyroid eye disease (TED) is a serious, progressive autoimmune disease with a limited window for pharmacologic treatment during the active disease. During this window, the disease may respond to pharmacologic intervention. During this webinar, we will discuss the progression of thyroid eye disease, as well as the symptoms, causes, management, and treatment modalities. 

    Learning Outcome: At the conclusion of this webinar, learners will be able to:
    1. Describe the causes of TED as well as the symptomatology and the progression of the disease.
    2. Discuss management and treatment options available for patients with this condition.

    Dr. Alon Kahana, MD, PhD

    Dr. Alon Kahana, MD, PhD, is an oculoplastic and orbital surgeon in Michigan, and founder of Kahana Oculoplastic and Orbital Surgery PLLC. Dr. Kahana serves as a professor of ophthalmology and vice chair for academic affairs at Oakland University William Beaumont School of Medicine. Following graduation from Brandeis University, he earned an MD and a PhD in molecular genetics and cell biology at The University of Chicago Pritzker School of Medicine. This education was followed by a residency in ophthalmology and a fellowship in oculofacial plastic and reconstructive surgery at the University of Wisconsin, Madison. Dr. Kahana served on the faculty of the University of Michigan Kellogg Eye Center, rising to the rank of associate professor with tenure. He left the University of Michigan in 2020 to start his own practice. Dr. Kahana’s research interests include tissue repair and regeneration, thyroid eye disease, cancer stem cells, and surgical outcomes. He has received numerous grants and awards, and serves as the president of the North American Society of Academic Orbital Surgeons.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: October 2, 2026

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits Recorded On: 09/12/2023

    Although infusion of fluids and medications is traditionally performed intravenously, venous depletion in patients has led to the quest for vessel health preservation. A safe, effective, acceptable, and efficient alternative is the subcutaneous route. However, a lack of organizational policies may contribute to the slow uptake of this practice. An international, interprofessional consensus panel adopted a modified e-Delphi approach to develop practice recommendations for subcutaneous infusion therapy. In this session, you will learn how you can safely administer subcutaneous infusion therapy and help preserve your patients’ veins.

    Although infusion of fluids and medications is traditionally performed intravenously, venous depletion in patients has led to the quest for vessel health preservation. A safe, effective, acceptable, and efficient alternative is the subcutaneous route. However, a lack of organizational policies may contribute to the slow uptake of this practice. An international, interprofessional consensus panel adopted a modified e-Delphi approach to develop practice recommendations for subcutaneous infusion therapy. In this session, you will learn how you can safely administer subcutaneous infusion therapy and help preserve your patients’ veins. 

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    • Describe indications/contraindications and risks/benefits of subcutaneous infusions.
    • Explain site assessment, device placement, and monitoring of subcutaneous infusions.
    • Identify strategies to support competency and quality. 

    Daphne Broadhurst, RN, MN, CVAA(c)

    Daphne Broadhurst is the director of clinical infusion services for Nipro Canada. She is proud to be a former adjunct research fellow with Griffith University, Australia and a past president of the Canadian Vascular Access Association. She is a costeering lead and coauthor of the 2024 Canadian Vascular Access and Infusion Therapy Guidelines and a coauthor of the International 2021 INS Standards of Infusion Therapy. She is published in 15 journals and has presented vascular access and infusion therapy best practices globally.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: September 12, 2026

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits Recorded On: 08/23/2023

    Over the last decade, infusion nurses have been increasingly challenged by patients presenting with difficult vascular access, which is often the result of age, comorbidities, or damage from previous failed vascular access devices. Selecting and inserting the right device to meet patients’ clinical needs has become more difficult, and has been worsened by complex organizational factors. Peripheral intravenous catheters (PIVCs) and peripherally inserted central catheters (PICC) continue to be the default devices chosen for short-to-moderate term peripherally compatible intravenous treatments. Although midline catheters (MCs) offer an alternate option, the uptake of this device has been limited due to a lack of clinical data supporting their use. This presentation will provide an overview of recent research involving MCs. It will include a summary of international guidelines and share the results from two recent randomised controlled trials (MCs vs PIVCs; MCs vs PICCs) conducted in Brisbane, Australia.

    Over the last decade, infusion nurses have been increasingly challenged by patients presenting with difficult vascular access, which is often the result of age, comorbidities, or damage from previous failed vascular access devices. Selecting and inserting the right device to meet patients’ clinical needs has become more difficult, and has been worsened by complex organizational factors. Peripheral intravenous catheters (PIVCs) and peripherally inserted central catheters (PICC) continue to be the default devices chosen for short-to-moderate term peripherally compatible intravenous treatments. Although midline catheters (MCs) offer an alternate option, the uptake of this device has been limited due to a lack of clinical data supporting their use. This presentation will provide an overview of recent research involving MCs. It will include a summary of international guidelines and share the results from two recent randomised controlled trials (MCs vs PIVCs; MCs vs PICCs) conducted in Brisbane, Australia.

    Learning Objectives: At the conclusion of this session, learners will be able to: 

    • Explain the complications associated with PIVCs, MCs, and PICCs.
    • Understand the different types of MCs available and how they meet clinical and organizational needs.
    • Describe the importance of MC surveillance.
    • Discuss the barriers faced by health care organizations introducing MCs.

    Dr Nicole Marsh, PhD, MAdvPrac, BN

    Dr. Nicole Marsh is the nursing and midwifery director of research at the Royal Brisbane and Women’s Hospital, the largest health service in Australia. Her program of research, which is underpinned by more than 100 publications, focuses on improving patient outcomes and decreasing complications associated with vascular access across the acute clinical care and community setting. She has recently quantified the international incidence of peripheral intravenous catheter failure and identified risk factors associated with this failure, and is currently leading a team who is investigating the clinical and economic benefit of different workforce models for vascular access device insertion to improve patient outcomes. In recognition of her expertise, Dr. Marsh was invited to advise on the development of the Australian Commission on Safety and Quality in Healthcare’s 2021 Peripheral Intravenous Catheter Clinical Care Standard, which all Australian hospitals are expected to use to support and monitor their clinical practice.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: August 23, 2026

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.